Showing results (41-50 of 99) with videos related to
Sort By:
Pageof 10
European Journal of Clinical Pharmacology|December 16, 1977
Comparison of the pharmacodynamic effects of furosemide and BAY g 2821 and correlation of the pharmacodynamics and pharmacokinetics of BAY g 2821 (muzolimine)D Loew, W Ritter, J DyckaHaemostasis|January 1, 1975
Influence of intravenously administered acetylsalicylic acid on platelet functions. A pharmacodynamic and pharmacokinetic studyH Vinazzer, J Pütter, D LoewCurrent Medical Research and Opinion|January 1, 1976
The diuretic effect of muzolimine (Bay g 2821) on hepatogenic ascitesF Heinrich, D Loew, J DýckaLife Sciences and Space Research|January 1, 1974
Preliminary results on the action of cosmic heavy ions on the development of eggs of Artemia salinaW Ruther, E H Graul, W Heinrich, et al.Journal of the American Podiatric Medical Association|March 1, 1991
Outgrowing trends in the lower extremities of childrenR O Schuster, J D SkliarArzneimittel-Forschung|January 1, 1982
[Human pharmacokinetics of different i.v. doses of azapropazone (HPLC-determination) (author's transl)]I Gikalov, R Kaufmann, O SchusterMMW Fortschritte Der Medizin|June 18, 2014
[Herbal medicines alternative to synthetical medicines]A M Beer, H Schilcher, D LoewInternational Journal of Clinical Pharmacology and Therapeutics|February 5, 2003
Differential therapy of constipation--a reviewR Wanitschke, K J Goerg, D LoewFortschritte Der Medizin|March 29, 1984
[Compatibility and efficacy of Meditonsin]D Loew, R Fuhr, F J BiboExperientia|March 15, 1977
3-Amino-1-(3,4-dichloro-alpha-methyl-benzyl)-2-pyrazolin-5-one (Bay g 2821), a potent diuretic from a new substance classE Möller, H Horstmann, K Meng, et al.Pageof 10